Rapamycin is a drug used to suppress the immune system in transplant patients, but scientists have discovered that the drug may have another use. The drug has been shown to have anti-aging properties, but so far no formal studies have been done on humans. Researchers are now investigating the drug to see if it could be used formally to treat some of the natural symptoms of aging.
Beyond the rules
a medicine Slowing aging may sound like science fiction, but it may one day become reality. Rapamycin “has gained a lot of traction thanks to longevity researchers and well-known physicians who cite animal studies to make their case.” [it] “This could potentially be a groundbreaking treatment for preventing age-related diseases.” The Washington PostBut the drug has not been officially approved by the Food and Drug Administration as a way to fight aging: “The agency doesn’t consider aging a disease, and because rapamycin is a generic drug, there’s little financial justification for conducting expensive clinical trials to test rapamycin for age-related diseases,” the Post reported.
To continue reading this article…
Create a free account
If you continue reading this article you will receive exclusive website access every month.
Do you already have an account? Sign in
Subscribe to The Week
You’ll receive unlimited website access, exclusive newsletters, and many other perks.
You can cancel or pause at any time.
Already a subscriber to The Week?
Digital and Print + Digital subscriptions include unlimited website access. Create an accountTo unlock access, please enter the same email address registered to your subscription.
